I received another thank you note from SOCK FIP regarding my recurring donation, so I visited their website to see if any new research was available from the UC Davis team. It appears that a closed clinical trial was conducted earlier in 2016 and a paper published about the findings. The PDF for the preliminary report is posted on SOCK FIP’s site date stamped 5/1/2016: http://www.sockfip.org/pdf/Preliminary_Report_5-1-2016.pdf

Within the report is a link to a published article regarding the emerging research. See PLOS.org for more detail. http://journals.plos.org/plospathogens/article?id=info:doi/10.1371/journal.ppat.1005531

While the news appear mostly positive in tone, please realize that this was a very small study. The brief also states that the protease inhibitor being tested isn’t available outside of UC Davis’ clinical trials program–and to further that limitation, the word “expensive” jumps right out of the page.

Obviously more trials are needed to determine the efficacy of the trial drug, and if found successful, it will take time to be federally evaluated before released for public consumption.